Virginia Steen

Virginia Steen practices at Medstar Medical Group II in Arlington, Virginia.

Virginia Steen's NPI, 1073513818, was assigned on July 22, 2005. Virginia Steen graduated from University of Pittsburgh School of Medicine in 1975. Virginia Steen holds District of Columbia license 21409.

Virginia Steen's primary practice is Medstar Medical Group II, at 2000 15th N St, Arlington, VA 22201 in Arlington County. The practice phone is (443) 444-5606.

Virginia Steen's primary practice is Medstar Medical Group II in Arlington, Virginia. Virginia Steen is also affiliated with MedStar Georgetown University Hospital. The medical group on file is MedStar Medical Group. Dmand AI also links Virginia Steen to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Virginia Steen practices. Vendor and product names are available with a free account.

Rheumatology is Virginia Steen's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Virginia Steen is licensed in District of Columbia.

CMS data shows 320 Medicare services from Virginia Steen across 6 procedure codes in 2024, for 161 Medicare patients. Medicare paid $31,216 for them. Every service was in an office.

CMS counts 161 Medicare patients who saw Virginia Steen in 2024. The largest group is 65 to 74, with 75 patients. 71% of them have high cholesterol, and 70% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Virginia Steen's median patient age at 60, with 80% women.

In 2024, Virginia Steen wrote 861 Medicare Part D claims for 105 patients. 87% of them were for generic drugs. CMS names the drug for 645 of them, across 23 drugs with 11 or more claims each, at $1,016,341 in total drug cost. In 2023, CMS named 602 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Virginia Steen for performance year 2024, reported as part of a group. Virginia Steen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Virginia Steen as offering telehealth.

Dmand AI links 91 papers to Virginia Steen, published from 2013 to 2025. 2020 was the busiest year, with 10. The most frequent topics are Scleroderma, Systemic, Scleroderma, Diffuse and Hypertension, Pulmonary. Virginia Steen has published most often in Arthritis Rheumatol. Virginia Steen's most frequent co-authors are Dinesh Khanna, MD, Lorinda Susan Chung, MD and Tracy Minan Frech, MD.

Dmand AI links Virginia Steen to 1 clinical trial. Conditions studied include Scleroderma, Systemic and Connective Tissue Diseases. Open Payments lists research payments to Virginia Steen that name 1 trial.

CMS Open Payments shows 200 general payments to Virginia Steen from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 70% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $119,094. It also lists 9 research payments totaling $1,351 in 2017, naming 1 clinical trial.

Virginia Steen graduated from University of Pittsburgh School of Medicine in 1975.